CytomX Therapeutics, Inc. (CTMX) NASDAQ

2.00

-0.09(-4.31%)

Updated at September 12 04:00PM

Currency In USD

Valuation

Market Cap86.97M
Enterprise Value58.31M
P/E Ratio5.38
PEG Ratio0.34
Price/Sales Ratio2.34
Price/Book Ratio2.15
Enterprise/Revenue2.04
Enterprise/EBITDA6.44

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.34
Operating Margin0.31

Management Effectiveness

Return On Assets0.27
Return On Equity1.59

Income Statement

Revenue138.1M
Revenue/Share1.09
Gross Profit138.1M
EBITDA26.76M
Net Income31.87M
Diluted EPS0.38

Balance Sheet

Total Cash158.09M
Total Cash/Share1.22
Total Debt6.89M
Total Debt/Equity0.06
Current Ratio4.2
Book Value Per Share0.93

Price History

52-Week Change62.6
52-Week High3.1
52-Week Low0.4
Moving Average 50 Days2.21
Moving Average 200 Days1.45

Statistics

Average Volume2.64M
Shares Outstanding164.91M
% Held by Institutions152.51

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A